Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
US-2019339288-A1 · Nov 7, 2019 · US
US10945940B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10945940-B2 |
| Application number | US-201615771747-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2016 |
| Priority date | Oct 29, 2015 |
| Publication date | Mar 16, 2021 |
| Grant date | Mar 16, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to methods of preparing an ultra-low molecular weight keratin peptide and use thereof. In particular, the present disclosure relates to a method of preparing an ultra-low molecular weight keratin peptide using culturing a microorganism having keratinolytic activity in a medium including keratin, ultrafiltration, ion exchange chromatography and gel filtration chromatography, a peptide prepared by the method, and a cosmetic and food composition for preventing or improving skin aging or skin wrinkles including the same. According to the method of preparing a keratin peptide of the present invention, it is possible to eco-friendly biologically treat waste resources and efficiently purify and recover anti-aging functional ultra-low molecular weight keratin peptides. In addition, the keratin peptide of the present disclosure breaks down collagen to have abilities to inhibit MMP-1 expression and activity, which is an enzyme that causes skin aging, which has an excellent effect on anti-skin aging and skin wrinkle improvement and has no toxicity to skin cells. It is suitable for use as a cosmetic, pharmaceutical or food composition for preventing, improving or treating skin aging or skin wrinkles, thereby being effectively used for the efficient and rapid production and development of high value-added functional cosmetic substances.
Opening claim text (preview).
What is claimed is: 1. A method for preventing or improving skin aging or skin wrinkles, the method comprising the step of treating a skin of subject with a cosmetic composition comprising a peptide comprising at least one sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 9. 2. The method of claim 1 , wherein the peptide is prepared by a method comprising the steps of: (1) obtaining keratin hydrolysates by culturing a microorganism having keratinolytic activity in a culture medium including keratin; (2) fractionating a protein having a molecular weight of 100 Da to 1000 Da in the keratin hydrolysates obtained from step (1); (3) purifying the protein by performing ion exchange chromatography, gel filtration chromatography or a combination thereof on the fractionated product obtained from step (2); and (4) purifying and desalting the protein by performing gel filtration chromatography on the purified protein obtained from step (3). 3. The method of claim 2 , wherein the microorganism in step (1) is Fervidobacterium islandicum AW-1 (KCTC4680). 4. The method of claim 2 , wherein the keratin in step (1) is derived from a feather, hair, leather, a nail, a claw, a horn or a hoof of a bird or a mammal. 5. The method of claim 2 , wherein the keratin in step (1) is derived from a feather of a bird. 6. The method of claim 5 , wherein the feather is present in the culture medium in an amount of 5 g/L to 15 g/L. 7. The method of claim 2 , wherein the culture in step (1) is an anaerobic culture. 8. The method of claim 2 , wherein the culture in step (1) is a static anaerobic culture. 9. The method of claim 2 , wherein the keratin peptide has an ability to inhibit matrix metalloproteinase-1 (MMP-1) expression or ability to inhibit MMP-1 activity. 10. The method of claim 2 , wherein the culture in step (1) is an anaerobic culture performed under a temperature condition of 60° C. to 90° C. 11. The method of claim 2 , wherein the fraction in step (2) is performed by ultrafiltration. 12. The method of claim 1 , wherein the skin aging is caused by ultraviolet rays. 13. The method of claim 1 , wherein the skin wrinkles is caused by ultraviolet rays. 14. The method of claim 1 , wherein the cosmetic composition comprising a peptide comprises SEQ ID NO: 9. 15. The method of claim 1 , wherein the cosmetic composition comprises a first peptide comprising SEQ ID NO: 9 and a second peptide selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 8.
produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00) · CPC title
Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Peptides; Protein hydrolysates · CPC title
Ion-exchange chromatography · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.